Cat. No. 1159
Biological ActivityStimulates bone formation by osteoblasts and inhibits bone resorption.
(Modifications: Disulfide bridge between 1 - 7, Pro-32 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
van Rossum et al (1997) Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci.Biobehav.Rev. 21 649. PMID: 9353797.
Poyner (1995) Pharmacology of receptors for calcitonin gene-related peptide and amylin. TiPS 16 424. PMID: 8578616.
If you know of a relevant reference for Calcitonin (salmon) please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Calcitonin (salmon) from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Calcitonin (salmon), supplier, bone, formation, resorption, AMY1, AMY2, AMY3, Amylin, CT, Calcitonin, agonist, Tocris Bioscience, Calcitonin and Related Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
Negative control for ELA-32 (Cat.No.6291).ELA-32 (human)
Potent, high affinity apelin receptor agonist; stimulates angiogenesisParathyroid hormone (1-34) (bovine)
Parathyroid hormone (PTH) receptor agonist.Parathyroid hormone (1-34) (rat)
Parathyroid hormone (PTH) receptor agonistPeptide YY (3-36) human
NPY Y2 receptor agonistELA-14 negative control
Negative control for ELA-14 (Cat.No.6293).ELA-14 (human)
Potent apelin (APJ) receptor agonistRetrobradykinin
Reverse analog of BradykininTASP 0390325
Potent and selective V1B receptor antagonist; orally bioavailable
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.